lung cancer

AZ’s immunotherapy combo misses the mark in untreated lung cancer

https://pharmaphorum.com/news/azs-immunotherapy-combo-misses-the-mark-in-untreated-lung-cancer/

Key Opinion Leaders to present at the Respiratory Drug Delivery Conference

https://pharmaphorum.com/partner-content/key-opinion-leaders-to-present-at-the-respiratory-drug-delivery-conference/

AZ’s lung cancer drug Tagrisso gets boost from first line OS results

https://pharmaphorum.com/news/azs-key-cancer-drug-tagrisso-gets-further-boost-from-os-results/

AstraZeneca and lung cancer: the pharmaphorum podcast

https://pharmaphorum.com/podcast/astrazeneca-and-lung-cancer

Lung cancer’s patient information gap: the pharmaphorum podcast

https://pharmaphorum.com/podcast/lung-cancers-patient-information-gap

BMS shares fall on mixed cancer immunotherapy results

https://pharmaphorum.com/news/bms-shares-fall-on-mixed-cancer-immunotherapy-results/

AZ says recovery to continue to despite patent expiry and Brexit headwinds

https://pharmaphorum.com/news/az-says-recovery-to-continue-to-despite-patent-expiry-and-brexit-headwinds/

Three Interactive Sessions to take place at the Respiratory Drug Delivery Conference

https://pharmaphorum.com/partner-content/three-interactive-sessions-to-take-place-at-the-respiratory-drug-delivery-conference/

Conference brochure for the inaugural Respiratory Drug Delivery now available

https://pharmaphorum.com/partner-content/conference-brochure-for-the-inaugural-respiratory-drug-delivery-now-available/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search